Sotac Pharmaceuticals Ltd
SOTAC
Sotac Pharmaceuticals Ltd
SOTAC
Sotac Pharmaceuticals Ltd Share Price
90.05 0.00 (0.00%)Fundamentals
Market Cap₹100Cr | EPS₹5.22 |
Book Value/Share₹42.67 | P/E Ratio (TTM)17.23 |
Industry P/E (TTM)45.66 | P/B Ratio1.86 |
Long Term D/E0.63 | ROE11.22% |
Dividend Yield (TTM)0.10% |
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Sotac Pharmaceuticals Ltd
The share price of Sotac Pharmaceuticals Ltd is ₹90.05 on NSE as of 29/8/2026, 12:03:39 am. Share prices may change frequently due to market movements.
The market capitalisation of Sotac Pharmaceuticals Ltd is ₹100Cr as of 29/8/2026, 12:03:39 am
The current Price to Earnings (P/E) ratio of Sotac Pharmaceuticals Ltd is 17.24 as of 29/8/2026, 12:03:39 am
The Price to Book (P/B) ratio of Sotac Pharmaceuticals Ltd stands at 1.87 as of 29/8/2026, 12:03:39 am
Sotac Pharmaceuticals Ltd reported an ROE of 11.23% for the last reported financial year on a consolidated account basis.
As of 29/8/2026, 12:03:39 am, Sotac Pharmaceuticals Ltd’s shareholding pattern is: promoters hold 72.80%, FIIs hold 16.80%, DIIs hold 0.00%, and public shareholders hold 10.40%.
The 52-week high of Sotac Pharmaceuticals Ltd is ₹90.05 and the 52-week low is ₹87.80 as of 29/8/2026, 12:03:39 am.
The earnings per share (EPS) of Sotac Pharmaceuticals Ltd is ₹0.38 for the quarter ended Sep 2024.
The stock symbol of Sotac Pharmaceuticals Ltd is SOTAC.
You can buy Sotac Pharmaceuticals Ltd shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Sotac Pharmaceuticals Ltd depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Sep 2024 | Q/Q Change |
|---|---|---|
| Operating Revenue | 27.35 | +8.32% |
| Other Income | 0.45 | +80.00% |
| Total Income | 27.80 | +9.02% |
| Total Expenditure | 25.24 | +9.60% |
| EBIDT | 2.56 | +4.07% |
| Depreciation | 0.74 | -1.33% |
| Interest | 0.60 | +42.86% |
| Tax | 0.80 | -1,700.00% |
| Net Profit | 0.46 | -68.28% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 77.68 |
| Total Non-Current Assets | 55.79 |
| Fixed assets | 49.47 |
| Total Assets | 133.47 |
| Total Current liabilities | 58.36 |
| Total Non Current Liabilities | 10.54 |
| Total Equity Plus Liabilities | 133.47 |
| Total Shareholder Funds | 58.87 |
| Total Debt to Equity | 64.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 16.87 |
| Cash from Financing Activities | -10.36 |
| Cash from Investing Activities | -6.90 |
| Net Cash Flow | -0.39 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages16
5 Day
91.0010 Day
96.2020 Day
102.3030 Day
103.8050 Day
106.80100 Day
116.10150 Day
118.90200 Day
117.50Indicators
RSI (14)
31.10MACD (12, 26)
-5.20MACD Signal Line (9)
-3.66MFI (14)
28.51ATR (14)
3.32ADX (14)
9.40ROC (21)
-15.05ROC (125)
-21.01Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 90.05 | 90.05 | 90.05 | 90.05 | 90.05 | 90.05 | 90.05 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Sep 2024 | Q/Q Change |
|---|---|---|
| Operating Revenue | 27.35 | +8.32% |
| Other Income | 0.45 | +80.00% |
| Total Income | 27.80 | +9.02% |
| Total Expenditure | 25.24 | +9.60% |
| EBIDT | 2.56 | +4.07% |
| Depreciation | 0.74 | -1.33% |
| Interest | 0.60 | +42.86% |
| Tax | 0.80 | -1,700.00% |
| Net Profit | 0.46 | -68.28% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 77.68 |
| Total Non-Current Assets | 55.79 |
| Fixed assets | 49.47 |
| Total Assets | 133.47 |
| Total Current liabilities | 58.36 |
| Total Non Current Liabilities | 10.54 |
| Total Equity Plus Liabilities | 133.47 |
| Total Shareholder Funds | 58.87 |
| Total Debt to Equity | 64.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 16.87 |
| Cash from Financing Activities | -10.36 |
| Cash from Investing Activities | -6.90 |
| Net Cash Flow | -0.39 |
Sotac Pharmaceuticals Ltd
SOTAC
Open Price | 90.05 |
Prev Close | 90.05 |
Upper Circuit | 94.55 |
Lower Circuit | 85.55 |
Volume | 3,600 |
Average Traded Price | 89.30 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |